Esthesioneuroblastoma staging: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 33: Line 33:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Cervical nodal metastases
*Cervical nodal metastases
|-
|}
{| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" align=center
|valign=top|
|+
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|T Classification}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Thickness}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:T1
| style="padding: 5px 5px; background: #F5F5F5;" |Tumor involvong the nasal cavity and/or paranasal sinuses (excluding sphenoid), sparing the most superior ethmoid cells
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:T2
| style="padding: 5px 5px; background: #F5F5F5;" |Tumor involving the nasal cavity and/or paranasal sinuses (including the sphenoid), with extention to or erosion of the cribiform plate
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:T3
| style="padding: 5px 5px; background: #F5F5F5;" |Tumor extending into the orbit or protruding into the anterior cranial fossa, without dural invasion
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:T4
| style="padding: 5px 5px; background: #F5F5F5;" |Tumor involving the brain
|-
|}
{| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" align=center
|valign=top|
|+
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|N Lymph Node}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Features}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:N0
| style="padding: 5px 5px; background: #F5F5F5;" |No cervical lymph node metastasis
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:N1
| style="padding: 5px 5px; background: #F5F5F5;" |Any form of cervical lymph node metastases
|-
|}
{| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" align=center
|valign=top|
|+
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|N Lymph Node}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Features}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:M0
| style="padding: 5px 5px; background: #F5F5F5;" |No metastasis
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:M1
| style="padding: 5px 5px; background: #F5F5F5;" |Distant Metastases
|-
|-
|}
|}

Revision as of 16:21, 15 January 2016

Esthesioneuroblastoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Esthesioneuroblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esthesioneuroblastoma staging On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esthesioneuroblastoma staging

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esthesioneuroblastoma staging

CDC on Esthesioneuroblastoma staging

Esthesioneuroblastoma staging in the news

Blogs on Esthesioneuroblastoma staging

Directions to Hospitals Treating Esthesioneuroblastoma

Risk calculators and risk factors for Esthesioneuroblastoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Staging

Group Features
Group A
  • Tumor is limited to the nasal cavity
Group B
  • Tumor is limited to the nasal cavity and paranasal sinuses
Group C
  • Tumor extends beyond the nasal cavity and paranasal sinuses
    • Base of skull
    • Intracranial compartment
    • Orbit
    • Distant metastatic disease
Group D
  • Cervical nodal metastases


T Classification Thickness
T1
Tumor involvong the nasal cavity and/or paranasal sinuses (excluding sphenoid), sparing the most superior ethmoid cells
T2
Tumor involving the nasal cavity and/or paranasal sinuses (including the sphenoid), with extention to or erosion of the cribiform plate
T3
Tumor extending into the orbit or protruding into the anterior cranial fossa, without dural invasion
T4
Tumor involving the brain
N Lymph Node Features
N0
No cervical lymph node metastasis
N1
Any form of cervical lymph node metastases
N Lymph Node Features
M0
No metastasis
M1
Distant Metastases

References

Template:Central nervous system tumors

Template:WH Template:WS